Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 209

1.

Stimulant drug action in attention deficit hyperactivity disorder (ADHD): inference of neurophysiological mechanisms via quantitative modelling.

Rowe DL, Robinson PA, Gordon E.

Clin Neurophysiol. 2005 Feb;116(2):324-35.

PMID:
15661111
[PubMed - indexed for MEDLINE]
2.

Effects of stimulant medications on children with attention-deficit/hyperactivity disorder and excessive beta activity in their EEG.

Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Clarke DC, Croft RJ.

Clin Neurophysiol. 2003 Sep;114(9):1729-37.

PMID:
12948803
[PubMed - indexed for MEDLINE]
3.

Biophysical modeling of tonic cortical electrical activity in attention deficit hyperactivity disorder.

Rowe DL, Robinson PA, Lazzaro IL, Powles RC, Gordon E, Williams LM.

Int J Neurosci. 2005 Sep;115(9):1273-305.

PMID:
16048806
[PubMed - indexed for MEDLINE]
4.

Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder.

Clarke AR, Barry RJ, Bond D, McCarthy R, Selikowitz M.

Psychopharmacology (Berl). 2002 Nov;164(3):277-84. Epub 2002 Sep 11.

PMID:
12424551
[PubMed - indexed for MEDLINE]
5.

Effects of stimulant medications on the EEG of girls with Attention-Deficit/Hyperactivity Disorder.

Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Johnstone SJ.

Clin Neurophysiol. 2007 Dec;118(12):2700-8. Epub 2007 Oct 2.

PMID:
17911040
[PubMed - indexed for MEDLINE]
6.

Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.

Williams LM, Hermens DF, Palmer D, Kohn M, Clarke S, Keage H, Clark CR, Gordon E.

Biol Psychiatry. 2008 May 15;63(10):917-26. doi: 10.1016/j.biopsych.2007.11.022. Epub 2008 Feb 13.

PMID:
18272140
[PubMed - indexed for MEDLINE]
7.

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.

Solanto MV.

Behav Brain Res. 1998 Jul;94(1):127-52. Review.

PMID:
9708845
[PubMed - indexed for MEDLINE]
8.

EEG differences between good and poor responders to methylphenidate and dexamphetamine in children with attention-deficit/hyperactivity disorder.

Clarke AR, Barry RJ, McCarthy R, Selikowitz M.

Clin Neurophysiol. 2002 Feb;113(2):194-205.

PMID:
11856625
[PubMed - indexed for MEDLINE]
9.

Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.

Stevenson RD, Wolraich ML.

Pediatr Clin North Am. 1989 Oct;36(5):1183-97. Review.

PMID:
2677938
[PubMed - indexed for MEDLINE]
10.

Event-related wave activity in the EEG provides new marker of ADHD.

Alexander DM, Hermens DF, Keage HA, Clark CR, Williams LM, Kohn MR, Clarke SD, Lamb C, Gordon E.

Clin Neurophysiol. 2008 Jan;119(1):163-79. Epub 2007 Nov 28.

PMID:
18054279
[PubMed - indexed for MEDLINE]
11.

EEG correlates of methylphenidate response among children with ADHD: a preliminary report.

Loo SK, Teale PD, Reite ML.

Biol Psychiatry. 1999 Jun 15;45(12):1657-60.

PMID:
10376129
[PubMed - indexed for MEDLINE]
12.

Effects of stimulant medication on the lateralisation of line bisection judgements of children with attention deficit hyperactivity disorder.

Sheppard DM, Bradshaw JL, Mattingley JB, Lee P.

J Neurol Neurosurg Psychiatry. 1999 Jan;66(1):57-63. Erratum in: J Neurol Neurosurg Psychiatry 2000 Feb;68(2):256.

PMID:
9886453
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

EEG differences between good and poor responders to methylphenidate in boys with the inattentive type of attention-deficit/hyperactivity disorder.

Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Croft RJ.

Clin Neurophysiol. 2002 Aug;113(8):1191-8.

PMID:
12139997
[PubMed - indexed for MEDLINE]
14.

Effects of stimulant medications on the EEG of children with Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive type.

Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Brown CR, Croft RJ.

Int J Psychophysiol. 2003 Feb;47(2):129-37.

PMID:
12568943
[PubMed - indexed for MEDLINE]
15.

Stimulant therapy in attention deficit/hyperactivity disorder.

Baldwin RL.

J Ark Med Soc. 2003 Dec;100(6):203-6. Review.

PMID:
14661403
[PubMed - indexed for MEDLINE]
16.

Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.

Preen DB, Calver J, Sanfilippo FM, Bulsara M, Holman CD.

Aust N Z J Public Health. 2007 Apr;31(2):120-6.

PMID:
17461001
[PubMed - indexed for MEDLINE]
17.

Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.

Lurie S, O'Quinn A.

J Neuropsychiatry Clin Neurosci. 1991 Winter;3(1):41-50. Review.

PMID:
7580171
[PubMed - indexed for MEDLINE]
18.

A two-part model of stimulant action on attention-deficit hyperactivity disorder in children.

McCracken JT.

J Neuropsychiatry Clin Neurosci. 1991 Spring;3(2):201-9. Review. No abstract available.

PMID:
1687963
[PubMed - indexed for MEDLINE]
19.

Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.

Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ.

J Dev Behav Pediatr. 2006 Feb;27(1):1-10.

PMID:
16511362
[PubMed - indexed for MEDLINE]
20.

EEG coherence in girls with attention-deficit/hyperactivity disorder: stimulant effects in good responders.

Dupuy FE, Clarke AR, Barry RJ, McCarthy R, Selikowitz M.

Int J Psychophysiol. 2008 Dec;70(3):151-7. doi: 10.1016/j.ijpsycho.2008.07.012. Epub 2008 Jul 25.

PMID:
18708101
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk